Private Capital Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$267K Sell
4,786
-1,318
-22% -$73.1K 0.2% 91
2022
Q1
$342K Sell
6,104
-124
-2% -$6.36K 0.08% 157
2021
Q4
$349K Sell
6,228
-180
-3% -$9.75K 0.07% 166
2021
Q3
$308K Buy
6,408
+1,288
+25% +$62.3K 0.07% 169
2021
Q2
$215K Buy
5,120
+310
+6% +$12K 0.05% 225
2021
Q1
$164K Sell
4,810
-14,850
-76% -$529K 0.04% 251
2020
Q4
$687K Buy
19,660
+240
+1% +$8.29K 0.13% 120
2020
Q3
$674K Sell
19,420
-896
-4% -$29.9K 0.14% 111
2020
Q2
$665K Sell
20,316
-3,172
-14% -$101K 0.14% 109
2020
Q1
$716K Buy
23,488
+7,536
+47% +$224K 0.19% 83
2019
Q4
$461K Sell
15,952
-150
-0.9% -$4.15K 0.1% 133
2019
Q3
$416K Buy
16,102
+8,166
+103% +$206K 0.07% 159
2019
Q2
$183K Sell
7,936
-8,650
-52% -$214K 0.04% 241
2019
Q1
$438K Buy
16,586
+5,022
+43% +$123K 0.08% 154
2018
Q4
$266K Buy
11,564
+3,858
+50% +$85.7K 0.06% 195
2018
Q3
$181K Sell
7,706
-556
-7% -$13.6K 0.04% 270
2018
Q2
$190K Buy
8,262
+252
+3% +$5.99K 0.04% 252
2018
Q1
$200K Sell
8,010
-36
-0.4% -$945 0.04% 241
2017
Q4
$216K Buy
+8,046
New +$205K 0.05% 231

Other funds holding NVO

Private Capital Group's NVO Position: Q2 2022 in Review

Private Capital Group reduced its Novo Nordisk (NVO) stake by 22% in Q2 2022, selling an estimated $73.1K and leaving 4,786 shares worth $267K. The position accounts for 0.2% of the portfolio, ranked #91.

Private Capital Group first reported a position in NVO in Q4 2017 and has held it in 19 quarters since. The position peaked at $716K in Q1 2020. 932 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

  • Private Capital Group held 4,786 shares of Novo Nordisk worth $267K as of Q2 2022.
  • Private Capital Group sold 1,318 Novo Nordisk shares in Q2 2022, an estimated $73.1K.
  • Novo Nordisk made up 0.2% of Private Capital Group's portfolio in Q2 2022, its #91 holding.
  • Private Capital Group first reported a position in Novo Nordisk in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Novo Nordisk position peaked at $716K in Q1 2020.
  • 932 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.